Literature DB >> 22744790

Consensus classification of human prion disease histotypes allows reliable identification of molecular subtypes: an inter-rater study among surveillance centres in Europe and USA.

Piero Parchi1, Laura de Boni, Daniela Saverioni, Mark L Cohen, Isidro Ferrer, Pierluigi Gambetti, Ellen Gelpi, Giorgio Giaccone, Jean-Jacques Hauw, Romana Höftberger, James W Ironside, Casper Jansen, Gabor G Kovacs, Annemieke Rozemuller, Danielle Seilhean, Fabrizio Tagliavini, Armin Giese, Hans A Kretzschmar.   

Abstract

The current classification of human sporadic prion diseases recognizes six major phenotypic subtypes with distinctive clinicopathological features, which largely correlate at the molecular level with the genotype at the polymorphic codon 129 (methionine, M, or valine, V) in the prion protein gene and with the size of the protease-resistant core of the abnormal prion protein, PrP(Sc) (i.e. type 1 migrating at 21 kDa and type 2 at 19 kDa). We previously demonstrated that PrP(Sc) typing by Western blotting is a reliable means of strain typing and disease classification. Limitations of this approach, however, particularly in the interlaboratory setting, are the association of PrP(Sc) types 1 or 2 with more than one clinicopathological phenotype, which precludes definitive case classification if not supported by further analysis, and the difficulty of fully recognizing cases with mixed phenotypic features. In this study, we tested the inter-rater reliability of disease classification based only on histopathological criteria. Slides from 21 cases covering the whole phenotypic spectrum of human sporadic prion diseases, and also including two cases of variant Creutzfeldt-Jakob disease (CJD), were distributed blindly to 13 assessors for classification according to given instructions. The results showed good-to-excellent agreement between assessors in the classification of cases. In particular, there was full agreement (100 %) for the two most common sporadic CJD subtypes and variant CJD, and very high concordance in general for all pure phenotypes and the most common subtype with mixed phenotypic features. The present data fully support the basis for the current classification of sporadic human prion diseases and indicate that, besides molecular PrP(Sc) typing, histopathological analysis permits reliable disease classification with high interlaboratory accuracy.

Entities:  

Mesh:

Year:  2012        PMID: 22744790      PMCID: PMC3725314          DOI: 10.1007/s00401-012-1002-8

Source DB:  PubMed          Journal:  Acta Neuropathol        ISSN: 0001-6322            Impact factor:   17.088


  39 in total

1.  Agent strain variation in human prion disease: insights from a molecular and pathological review of the National Institutes of Health series of experimentally transmitted disease.

Authors:  Piero Parchi; Maura Cescatti; Silvio Notari; Walter J Schulz-Schaeffer; Sabina Capellari; Armin Giese; Wen-Quan Zou; Hans Kretzschmar; Bernardino Ghetti; Paul Brown
Journal:  Brain       Date:  2010-09-07       Impact factor: 13.501

2.  Sporadic Creutzfeldt-Jakob disease: co-occurrence of different types of PrP(Sc) in the same brain.

Authors:  G Puoti; G Giaccone; G Rossi; B Canciani; O Bugiani; F Tagliavini
Journal:  Neurology       Date:  1999-12-10       Impact factor: 9.910

3.  MM2-thalamic Creutzfeldt-Jakob disease: neuropathological, biochemical and transmission studies identify a distinctive prion strain.

Authors:  Fabio Moda; Silvia Suardi; Giuseppe Di Fede; Antonio Indaco; Lucia Limido; Chiara Vimercati; Margherita Ruggerone; Ilaria Campagnani; Jan Langeveld; Alessandro Terruzzi; Antonio Brambilla; Pietro Zerbi; Paolo Fociani; Matthew T Bishop; Robert G Will; Jean C Manson; Giorgio Giaccone; Fabrizio Tagliavini
Journal:  Brain Pathol       Date:  2012-02-21       Impact factor: 6.508

4.  Inter-laboratory assessment of PrPSc typing in creutzfeldt-jakob disease: a Western blot study within the NeuroPrion Consortium.

Authors:  Piero Parchi; Silvio Notari; Petra Weber; Heinz Schimmel; Herbert Budka; Isidre Ferrer; Stéphane Haik; Jean-Jacques Hauw; Mark W Head; James W Ironside; Lucia Limido; Agustin Rodriguez; Thomas Ströbel; Fabrizio Tagliavini; Hans A Kretzschmar
Journal:  Brain Pathol       Date:  2008-07-02       Impact factor: 6.508

5.  Strain characterization of natural sheep scrapie and comparison with BSE.

Authors:  Moira E Bruce; Aileen Boyle; Simon Cousens; Irene McConnell; James Foster; Wilfred Goldmann; Hugh Fraser
Journal:  J Gen Virol       Date:  2002-03       Impact factor: 3.891

6.  Fatal familial insomnia and familial Creutzfeldt-Jakob disease: different prion proteins determined by a DNA polymorphism.

Authors:  L Monari; S G Chen; P Brown; P Parchi; R B Petersen; J Mikol; F Gray; P Cortelli; P Montagna; B Ghetti
Journal:  Proc Natl Acad Sci U S A       Date:  1994-03-29       Impact factor: 11.205

7.  Genetic influence on the structural variations of the abnormal prion protein.

Authors:  P Parchi; W Zou; W Wang; P Brown; S Capellari; B Ghetti; N Kopp; W J Schulz-Schaeffer; H A Kretzschmar; M W Head; J W Ironside; P Gambetti; S G Chen
Journal:  Proc Natl Acad Sci U S A       Date:  2000-08-29       Impact factor: 11.205

8.  Variably protease-sensitive prionopathy: a new sporadic disease of the prion protein.

Authors:  Wen-Quan Zou; Gianfranco Puoti; Xiangzhu Xiao; Jue Yuan; Liuting Qing; Ignazio Cali; Miyuki Shimoji; Jan P M Langeveld; Rudy Castellani; Silvio Notari; Barbara Crain; Robert E Schmidt; Michael Geschwind; Stephen J Dearmond; Nigel J Cairns; Dennis Dickson; Lawrence Honig; Juan Maria Torres; James Mastrianni; Sabina Capellari; Giorgio Giaccone; Ermias D Belay; Lawrence B Schonberger; Mark Cohen; George Perry; Qingzhong Kong; Piero Parchi; Fabrizio Tagliavini; Pierluigi Gambetti
Journal:  Ann Neurol       Date:  2010-08       Impact factor: 10.422

9.  Experimental verification of a traceback phenomenon in prion infection.

Authors:  Atsushi Kobayashi; Nobuyuki Sakuma; Yuichi Matsuura; Shirou Mohri; Adriano Aguzzi; Tetsuyuki Kitamoto
Journal:  J Virol       Date:  2010-01-20       Impact factor: 5.103

Review 10.  Sporadic and familial CJD: classification and characterisation.

Authors:  Pierluigi Gambetti; Qingzhong Kong; Wenquan Zou; Piero Parchi; Shu G Chen
Journal:  Br Med Bull       Date:  2003       Impact factor: 4.291

View more
  82 in total

1.  Evidence for human transmission of amyloid-β pathology and cerebral amyloid angiopathy.

Authors:  Zane Jaunmuktane; Simon Mead; Matthew Ellis; Jonathan D F Wadsworth; Andrew J Nicoll; Joanna Kenny; Francesca Launchbury; Jacqueline Linehan; Angela Richard-Loendt; A Sarah Walker; Peter Rudge; John Collinge; Sebastian Brandner
Journal:  Nature       Date:  2015-09-10       Impact factor: 49.962

2.  Longitudinal clinical, neuropsychological, and neuroimaging characterization of a kindred with a 12-octapeptide repeat insertion in PRNP: the next generation.

Authors:  Ryan A Townley; Angelina J Polsinelli; Julie A Fields; Mary M Machulda; David T Jones; Jonathan Graff-Radford; Kejal M Kantarci; Val J Lowe; Rosa V Rademakers; Matt C Baker; Neeraj Kumar; Bradley F Boeve
Journal:  Neurocase       Date:  2020-06-30       Impact factor: 0.881

3.  No reactivation of JCV and CMV infections in the temporal cortex and cerebellum of sporadic Creutzfeldt-Jakob disease patients.

Authors:  Judith Löffler; Susanne Krasemann; Inga Zerr; Jakob Matschke; Markus Glatzel
Journal:  Am J Neurodegener Dis       Date:  2014-12-05

4.  Cerebrospinal Fluid Total Prion Protein in the Spectrum of Prion Diseases.

Authors:  Anna Villar-Piqué; Matthias Schmitz; Ingolf Lachmann; André Karch; Olga Calero; Christiane Stehmann; Shannon Sarros; Anna Ladogana; Anna Poleggi; Isabel Santana; Isidre Ferrer; Eva Mitrova; Dana Žáková; Maurizio Pocchiari; Inês Baldeiras; Miguel Calero; Steven J Collins; Michael D Geschwind; Raquel Sánchez-Valle; Inga Zerr; Franc Llorens
Journal:  Mol Neurobiol       Date:  2018-07-30       Impact factor: 5.590

5.  Diagnostic and prognostic value of human prion detection in cerebrospinal fluid.

Authors:  Aaron Foutz; Brian S Appleby; Clive Hamlin; Xiaoqin Liu; Sheng Yang; Yvonne Cohen; Wei Chen; Janis Blevins; Cameron Fausett; Han Wang; Pierluigi Gambetti; Shulin Zhang; Andrew Hughson; Curtis Tatsuoka; Lawrence B Schonberger; Mark L Cohen; Byron Caughey; Jiri G Safar
Journal:  Ann Neurol       Date:  2017-01       Impact factor: 10.422

Review 6.  Advanced tests for early and accurate diagnosis of Creutzfeldt-Jakob disease.

Authors:  Gianluigi Zanusso; Salvatore Monaco; Maurizio Pocchiari; Byron Caughey
Journal:  Nat Rev Neurol       Date:  2016-05-13       Impact factor: 42.937

7.  A test for Creutzfeldt-Jakob disease using nasal brushings.

Authors:  Christina D Orrú; Matilde Bongianni; Giovanni Tonoli; Sergio Ferrari; Andrew G Hughson; Bradley R Groveman; Michele Fiorini; Maurizio Pocchiari; Salvatore Monaco; Byron Caughey; Gianluigi Zanusso
Journal:  N Engl J Med       Date:  2014-08-07       Impact factor: 91.245

8.  Diagnostic value of surrogate CSF biomarkers for Creutzfeldt-Jakob disease in the era of RT-QuIC.

Authors:  Samir Abu-Rumeileh; Simone Baiardi; Barbara Polischi; Angela Mammana; Alessia Franceschini; Alison Green; Sabina Capellari; Piero Parchi
Journal:  J Neurol       Date:  2019-09-20       Impact factor: 4.849

9.  Detection of Atypical H-Type Bovine Spongiform Encephalopathy and Discrimination of Bovine Prion Strains by Real-Time Quaking-Induced Conversion.

Authors:  Kentaro Masujin; Christina D Orrú; Kohtaro Miyazawa; Bradley R Groveman; Lynne D Raymond; Andrew G Hughson; Byron Caughey
Journal:  J Clin Microbiol       Date:  2016-01-06       Impact factor: 5.948

10.  Analysis of RNA Expression Profiles Identifies Dysregulated Vesicle Trafficking Pathways in Creutzfeldt-Jakob Disease.

Authors:  Anna Bartoletti-Stella; Patrizia Corrado; Nicola Mometto; Simone Baiardi; Pascal F Durrenberger; Thomas Arzberger; Richard Reynolds; Hans Kretzschmar; Sabina Capellari; Piero Parchi
Journal:  Mol Neurobiol       Date:  2018-11-16       Impact factor: 5.590

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.